Podcast


Presenter: Dr. James McCormack Dr. Michael Allan

In episode 558, Mike and James decide to start to tackle the ketamine for depression story. Mike talks about what the media says about ketamine and then he delves into what the guidelines say. Then as always, we discuss the best available evidence. Have a listen so that you can be in the know about…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here



CFPCLearn Logo

Listening to the Podcast can earn you MainPro+ Credits

Join Now

Already a CFPCLearn Member? Log in



Latest Podcasts

CFP Podcast: Graphic medicine

Have you ever heard of graphic medicine? Have you wondered what is the difference between a comic and a cartoon? And how is this related to your work in the…
Listen 0.5 credits available

BS Medicine Episode #583: Reducing the risk associated with risk calculators – PART II

In episode 583, Mike and James continue to go over the issues associated with using CVD risk calculators. We talk about some of the limitations, how to think about the…
Listen 0.5 credits available

BS Medicine Episode #582: Reducing the risk associated with risk calculators

In episode 582, Mike and James go over the issues associated with using CVD risk calculators. We talk about where the numbers come from, what they mean, what their limitations…
Listen 0.5 credits available

Presenter(s):

Dr. James McCormack Dr. Michael Allan

This content is certified for MainPro+ Credits, log in to access


Presenter(s):

  • Dr. James McCormack
  • Dr. Michael Allan

Spearkers do not have any conflicts of interest to declare.